DAMME LAURA
SEC CIK 1784433 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TMDX | TransMedics Group, Inc. | VP, Clinical Affairs | 5,685 | — | $665.7K | 3 | 2022-12-14 | 2023-02-20 |
Most active insiders at TMDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Weill David | Dir | $109.1K | $1.22M |
| 2 | Hernandez Gerardo | CFO | — | $1.25M |
| 3 | Hassanein Waleed H | Pres, CEO, Dir | $1.00M | — |
| 4 | Gunderson Thomas J. | Dir | — | $722.4K |
| 5 | Ranganath Anil P. | See remarks | — | $555.9K |
| 6 | Basile Edward M | Dir | — | $540.3K |
| 7 | Corcoran Nicholas | See remarks | — | $412.6K |
| 8 | Lovell Stephanie | Dir | — | $178.5K |
| 9 | Forsyth Matthew S. | See Remarks | — | — |
| 10 | Cecere Giovanni | Chief Commercial Off | — | — |
DAMME LAURA made no open-market trades at TMDX in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-22 | 2023-02-20 | TMDX | TransMedics Group, Inc. | DAMME LAURA | VP, Clinical Affairs | A - Grant | $0.00 | +5,685 | 5,685 | New | $0 |
| DM | 2022-12-16 | 2022-12-14+ | TMDX | TransMedics Group, Inc. | DAMME LAURA | VP, Clinical Affairs | M - OptEx | $38.46 | +10.9K | 5,947 | New | +$420.6K |
| DM | 2022-12-16 | 2022-12-14+ | TMDX | TransMedics Group, Inc. | DAMME LAURA | VP, Clinical Affairs | S - Sale+OE | $60.87 | -10.9K | 0 | -100% | -$665.7K |
Purchase Sale Sale after option exercise All abbreviations